Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
boston
boston blog main
boston top stories
clinical trials
fda
hereditary transthyretin amyloidosis
life sciences
national blog main
national top stories
2
×
patisiran
rna interference
akcea therapeutics
alexion pharmaceuticals
andrew fire
biotech
boehringer ingelheim
craig mello
deals
dicerna pharamceuticals
hepatitis b
hepatitis b virus
inotersen
john maraganore
new york blog main
new york top stories
nobel prize
onpattro
pfizer
roche
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
tafamidis
vyndaqel
world health organization
What
drug
2
×
pharmaceuticals
2
×
afternoon
alnylam
alnylam’s
approved
caught
causing
dicerna
disease
eye
fda
gene
gets
hepatitis
history
intended
landmark
making
medicine
medicines
ok
onpattro
patisiran
pay
pharma
producing
protein
research
rnai
roche
specifically
stop
team
Language
unset
Current search:
pharmaceuticals
×
drug
×
" national top stories "
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug